STATEMENT OF DIRECTORS' RESPONSIBILITIES |
|
The Directors are responsible for preparing the Annual Report and the Financial Statements in accordance with applicable law and regulations. Company law requires the Directors to prepare Financial Statements for each financial year and the Directors have elected to prepare the Financial Statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Directors must not approve the Financial Statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these Financial Statements, the Directors are required to: • select suitable accounting policies and then apply them consistently; • make judgements and accounting estimates that are reasonable and prudent; • state whether the Financial Statements have been prepared in accordance with United Kingdom accounting standards, subject to any material departures disclosed and explained in the Financial Statements; • prepare the Financial Statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business; • prepare a Strategic Report, a Director's Report and Directors' Remuneration Report which comply with the requirements of the Companies Act 2006. The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the Financial Statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Website publication The Directors are responsible for ensuring the Annual Report and the Financial Statements are made available on a website. Financial Statements are published on the Company's website in accordance with legislation in the United Kingdom governing the preparation and dissemination of Financial Statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the Company's website is the responsibility of the Directors. The Directors' responsibility also extends to the ongoing integrity of the Financial Statements contained therein. Directors' responsibilities pursuant to Disclosure and Transparency Rule 4 of the UK Listing Authority The Directors confirm to the best of their knowledge that: (a) The Financial Statements, which have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice, give a true and fair view of the assets, liabilities, financial position and the profit of the Company. (b) The Annual Report includes a fair review of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that it faces. Having taken advice from the Audit Committee, the Board considers the Annual Report and Accounts, taken as a whole, is fair, balanced and understandable and that it provides the information necessary for shareholders to assess the Company's performance, business model and strategy. Neither the Company nor the Directors accept any liability to any person in relation to the Annual Report except to the extent that such liability could arise under English law. For and on behalf of the Board Clive Boothman Chairman |
|
FINANCIAL STATEMENTS |
|
|
Income Statement for the year ended 31 December 2018 |
|
|
|
|
|
|
Year ended 31 December 2018 |
Year ended 31 December 2017 |
|
|
|
|
|
|
|
|
|
Notes |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealised gains/(losses) on investments |
8 |
- |
2,796,306 |
2,796,306 |
- |
(572,662) |
(572,662) |
|
|
|
|
|
|
|
|
Realised (losses)/gains on investments |
8 |
- |
(129,014) |
(129,014) |
- |
5,248,859 |
5,248,859 |
|
|
|
|
|
|
|
|
Income |
3 |
3,219,294 |
- |
3,219,294 |
3,131,481 |
- |
3,131,481 |
|
|
|
|
|
|
|
|
Investment Adviser's fees |
4a |
(390,531) |
(1,171,593) |
(1,562,124) |
(350,079) |
(1,050,237) |
(1,400,316) |
|
|
|
|
|
|
|
|
Other expenses |
4c |
(387,232) |
- |
(387,232) |
(385,417) |
- |
(385,417) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit on ordinary activities before taxation |
|
2,441,531 |
1,495,699 |
3,937,230 |
2,395,985 |
3,625,960 |
6,021,945 |
|
|
|
|
|
|
|
|
Taxation on profit on ordinary activities |
5 |
(331,416) |
222,603 |
(108,813) |
(392,180) |
202,170 |
(190,010) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year and total comprehensive income |
|
2,110,115 |
1,718,302 |
3,828,417 |
2,003,805 |
3,828,130 |
5,831,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share |
7 |
1.98p |
1.62p |
3.60p |
2.52p |
4.82p |
7.34p |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the unrealised gains/(losses) and realised (losses)/gains on investments and the proportion of the Investment Adviser's fee charged to capital. The total column is the Statement of Total Comprehensive Income of the Company prepared in accordance with Financial Reporting Standards ("FRS"). In order to better reflect the activities of a VCT and in accordance with the 2014 Statement of Recommended Practice ("SORP") (updated in January 2017) by the Association of Investment Companies ("AIC"), supplementary information which analyses the Income Statement between items of a revenue and capital nature has been presented alongside the Income Statement. The revenue column of profit attributable to equity shareholders is the measure the Directors believe appropriate in assessing the Company's compliance with certain requirements set out in Section 274 Income Tax Act 2007. |
|
All the items in the above statement derive from continuing operations of the Company. No operations were acquired or discontinued in the year. |
|
|
|
Balance Sheet as at 31 December 2018 |
|
|
|
|
|
|
|
Notes |
31 December 2018 |
31 December 2017 |
|
|
|
£ |
£ |
|
|
|
|
|
Fixed assets |
|
|
|
Investments at fair value |
8 |
48,195,051 |
41,515,308 |
Current assets |
|
|
|
Debtors and prepayments |
|
793,953 |
3,976,235 |
Current asset investments |
9 |
23,310,315 |
21,803,276 |
Cash at bank and in hand |
9 |
3,181,475 |
3,027,719 |
|
|
27,285,743 |
28,807,230 |
|
|
|
|
Creditors: amounts falling due within one year |
|
(402,812) |
(422,761) |
|
|
|
|
Net current assets |
|
26,882,931 |
28,384,469 |
|
|
|
|
Net assets |
|
75,077,982 |
69,899,777 |
|
|
|
|
Capital and reserves |
|
|
|
Called up share capital |
|
1,068,659 |
974,257 |
Capital redemption reserve |
|
32,191 |
15,040 |
Share premium reserve |
|
43,644,698 |
35,856,430 |
Revaluation reserve |
|
5,285,632 |
2,786,782 |
Special distributable reserve |
|
12,681,614 |
19,058,094 |
Realised capital reserve |
|
8,818,475 |
8,147,387 |
Revenue reserve |
|
3,546,713 |
3,061,787 |
|
|
|
|
Equity shareholders' funds |
|
75,077,982 |
69,899,777 |
|
|
|
|
Basic and diluted net asset value per ordinary share |
|
70.25p |
71.75p |
|
|
|
Statement of Changes in Equity for the year ended 31 December 2018 |
|
|
|
|
|
|
|
|
|
|
Distributable Reserves |
Non-Distributable Reserves |
|
|
|
|
|
|
|
|
|
|
|
Called up share capital |
Capital redemption reserve |
Share premium reserve |
Revaluation reserve |
Special distributable reserve (Note a) |
Realised capital reserve (Note b) |
Revenue Reserve (Note b) |
Total |
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2018 Comprehensive income for the year |
974,257 |
15,040 |
35,856,430 |
2,786,782 |
19,058,094 |
8,147,387 |
3,061,787 |
69,899,777 |
|
|
|
|
|
|
|
|
|
Profit/(loss) for the year |
- |
- |
- |
2,796,306 |
- |
(1,078,004) |
2,110,115 |
3,828,417 |
Total comprehensive income for the year |
- |
- |
- |
2,796,306 |
- |
(1,078,004) |
2,110,115 |
3,828,417 |
Contributions by and distributions to owners |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under Offer for Subscription (note c) |
111,553 |
- |
7,788,268 |
- |
(82,001) |
- |
- |
7,817,820 |
|
|
|
|
|
|
|
|
|
Shares bought back (note d) |
(17,151) |
17,151 |
- |
- |
(1,058,135) |
- |
- |
(1,058,135) |
|
|
|
|
|
|
|
|
|
Dividends paid |
- |
- |
- |
- |
(3,242,978) |
(541,730) |
(1,625,189) |
(5,409,897) |
Total contributions by and distributions to owners |
94,402 |
17,151 |
7,788,268 |
- |
(4,383,114) |
(541,730) |
(1,625,189) |
1,349,788 |
Other movements |
|
|
|
|
|
|
|
|
Realised losses transferred to special reserve (note a) |
- |
- |
- |
- |
(1,993,366) |
1,993,366 |
- |
- |
Realisation of previously unrealised appreciation |
- |
- |
- |
(297,456) |
- |
297,456 |
- |
- |
Total other movements |
- |
- |
- |
(297,456) |
(1,993,366) |
2,290,822 |
- |
- |
At 31 December 2018 |
1,068,659 |
32,191 |
43,644,698 |
5,285,632 |
12,681,614 |
8,818,475 |
3,546,713 |
75,077,982 |
|
Note a: The purpose of this reserve is to fund market purchases of the Company's own shares, to write off existing and future losses and for any other corporate purpose. All of this reserve arose from shares issued before 5 April 2014. The transfer of £1,993,366 to the special reserve from the realised capital reserve above is the total of realised losses incurred by the Company in the year. |
|
Note b: The realised capital reserve and the revenue reserve together comprise the Profit and Loss Account of the Company shown on the Balance Sheet. |
|
Note c: Under the 2017/18 Offer for Subscription, 11,155,262 ordinary shares were allotted raising net funds of £7,817,820 for the Company. This figure is net of issue costs of £204,683. |
|
Note d: During the year, the Company purchased 1,715,113 of its own shares at the prevailing market price for a total cost of £1,058,135, which were subsequently cancelled. This differs to the figure shown in the Statement of Cash Flows of £982,450 by £75,685 due to £122,542 included in creditors at the year end, offset by £46,857 which was a creditor from the previous year. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Changes in Equity for the year ended 31 December 2017 |
|
|
|
|
|
|
|
|
|
|
Distributable Reserves |
Non-Distributable Reserves |
|
|
|
|
|
|
|
|
|
|
|
Called up share capital |
Capital redemption reserve |
Share premium reserve |
Revaluation reserve |
Special distributable reserve |
Realised capital reserve |
Revenue reserve |
Total |
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
At 1 January 2017 |
755,975 |
9,440 |
19,463,849 |
3,523,180 |
35,605,335 |
2,733,792 |
1,057,982 |
63,149,553 |
|
|
|
|
|
|
|
|
|
Comprehensive income for the year |
|
|
|
|
|
|
|
|
(Loss)/profit for the year |
- |
- |
- |
(572,662) |
- |
4,400,792 |
2,003,805 |
5,831,935 |
Total comprehensive income for the year |
- |
- |
- |
(572,662) |
- |
4,400,792 |
2,003,805 |
5,831,935 |
|
|
|
|
|
|
|
|
|
Contributions by and distributions to owners |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued under Offer for Subscription |
223,882 |
- |
16,392,581 |
- |
(91,557) |
- |
- |
16,524,906 |
|
|
|
|
|
|
|
|
|
Shares bought back |
(5,600) |
5,600 |
- |
- |
(374,695) |
- |
- |
(374,695) |
|
|
|
|
|
|
|
|
|
Dividends paid |
- |
- |
- |
- |
(15,231,922) |
- |
- |
(15,231,922) |
Total contributions by and distributions to owners |
218,282 |
5,600 |
16,392,581 |
- |
(15,698,174) |
- |
- |
918,289 |
Other movements |
|
|
|
|
|
|
|
|
Realised losses transferred to special reserve |
- |
- |
- |
- |
(849,067) |
849,067 |
- |
- |
Realisation of previously unrealised appreciation |
- |
- |
- |
(163,736) |
- |
163,736 |
- |
- |
Total other movements |
- |
- |
- |
(163,736) |
(849,067) |
1,012,803 |
- |
- |
At 31 December 2017 |
974,257 |
15,040 |
35,856,430 |
2,786,782 |
19,058,094 |
8,147,387 |
3,061,787 |
69,899,777 |
|
The composition of each of these reserves is explained below: |
|
Called up share capital |
The nominal value of shares originally issued, increased for subsequent share issues either via an Offer for Subscription or reduced due to shares bought back by the Company. |
|
Capital redemption reserve |
The nominal value of shares bought back and cancelled is held in this reserve, so that the company's capital is maintained. |
|
Share premium reserve |
This reserve contains the excess of gross proceeds less issue costs over the nominal value of shares allotted under recent Offers for Subscription. |
|
Revaluation reserve |
Increases and decreases in the valuation of investments held at the year end are accounted for in this reserve, except to the extent that the diminution is deemed permanent. In accordance with stating all investments at fair value through profit and loss (as recorded in note 8), all such movements through both revaluation and realised capital reserves are shown within the Income Statement for the year. |
|
Special distributable reserve |
The cost of share buybacks is charged to this reserve. In addition, any realised losses on the sale or impairment of investments (excluding transaction costs), and 75% of the Investment Adviser fee expense, and the related tax effect, are transferred from the realised capital reserve to this reserve. This reserve will also be charged any facilitation payments to financial advisers, which arose as part of the Offer for Subscription. |
|
Realised capital reserve |
The following are accounted for in this reserve: • Gains and losses on realisation of investments; • Permanent diminution in value of investments; • Transaction costs incurred in the acquisition and disposal of investments; • 75% of the Investment Adviser fee expense and 100% of any performance fee payable, together with the related tax effect to this reserve in accordance with the policies; and • Capital dividends paid. |
|
Revenue reserve |
Income and expenses that are revenue in nature are accounted for in this reserve together with the related tax effect, as well as income dividends paid that are classified as revenue in nature. |
|
|
Statement of Cash Flows for the year ended 31 December 2018 |
|
|
|
Year ended 31 December 2018 |
Year ended December 2017 |
|
|
£ |
£ |
|
|
|
|
Cash flows from operating activities |
|
|
|
Profit after tax for the financial year |
|
3,828,417 |
5,831,935 |
Adjustments for: |
|
|
|
Net unrealised losses on investments |
|
(2,796,306) |
572,662 |
Net gains on realisations of investments |
|
129,014 |
(5,248,859) |
Tax charge for current year |
5 |
108,813 |
190,010 |
Decrease/(increase) in debtors |
|
12,155 |
(197,500) |
(Decrease)/increase in creditors |
|
(14,106) |
92,991 |
Net cash inflow from operations |
|
1,267,987 |
1,241,239 |
|
|
|
|
Corporation tax paid |
|
(190,374) |
(109,090) |
Net cash inflow from operating activities |
|
1,077,613 |
1,132,149 |
|
|
|
|
Cash flows from investing activities |
|
|
|
Acquisitions of investments |
8 |
(7,238,337) |
(1,649,533) |
Disposals of investments |
8 |
6,396,046 |
13,821,745 |
(Increase)/decrease in bank deposits with a maturity over three months |
|
(130) |
1,715 |
Net cash (outflow)/inflow from investing activities |
|
(842,421) |
12,173,927 |
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
Shares issued as part of Offer for subscription |
|
7,817,820 |
16,524,906 |
Equity dividends paid |
6 |
(5,409,897) |
(15,231,922) |
Share capital bought back |
|
(982,450) |
(327,838) |
Net cash inflow from financing activities |
|
1,425,473 |
965,146 |
|
|
|
|
Net increase in cash and cash equivalents |
|
1,660,665 |
14,271,222 |
Cash and cash equivalents at start of year |
|
23,825,443 |
9,554,221 |
Cash and cash equivalents at end of year |
|
25,486,108 |
23,825,443 |
|
|
|
|
Cash and cash equivalents comprise: |
|
|
|
Cash equivalents |
9 |
22,304,633 |
20,797,724 |
Cash at bank and in hand |
9 |
3,181,475 |
3,027,719 |
|
|
|
Notes to the Financial Statements for the year ended 31 December 2018 |
|
1 |
Company Information |
|
|
Mobeus Income and Growth VCT plc is a public limited company incorporated in England, registration number 5153931. The registered office is 30 Haymarket, London, SW1Y 4EX. |
|
|
2 |
Basis of preparation of the Financial Statements |
|
A summary of the principal accounting policies, all of which have been applied consistently throughout the year are set out at the start of the related disclosure throughout the Notes to the Financial Statements. All accounting policies are included within an outlined box at the top of each relevant note. These financial statements have been prepared in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 ("FRS102"), with the Companies Act 2006 and the 2014 Statement of Recommended practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('the SORP') issued by the Association of Investment Companies. The Company has a number of financial instruments which are disclosed under FRS102 s11/12 as shown in Note 15 in the Financial Statements in the Annual Report. |
3 |
Income |
|
Dividends receivable on quoted equity shares are brought into account on the ex-dividend date. Dividends receivable on unquoted equity shares are brought into account when the Company's right to receive payment is established and there is no reasonable doubt that payment will be received. Interest income on loan stock is accrued on a daily basis. Provision is made against this income where recovery is doubtful or where it will not be received in the foreseeable future. Where the loan stocks only require interest or a redemption premium to be paid on redemption, the interest and redemption premium is recognised as income or capital as appropriate once redemption is reasonably certain. When a redemption premium is designed to protect the value of the instrument holder's investment rather than reflect a commercial rate of revenue return the redemption premium is recognised as capital. The treatment of redemption premiums is analysed to consider if they are revenue or capital in nature on a company by company basis. Accordingly, the redemption premium recognised in the year ended 31 December 2018 has been classified as capital and has been included within gains on investments. |
|
|
2018 |
2017 |
|
£ |
£ |
Income from bank deposits |
23,663 |
17,793 |
|
|
|
Income from investments |
|
|
- from equities |
699,029 |
358,684 |
- from OEIC funds |
132,832 |
23,657 |
- from loan stock |
2,321,462 |
2,723,814 |
- from interest on preference share dividend arrears |
40,205 |
337 |
|
3,193,528 |
3,106,492 |
|
|
|
Other income |
2,103 |
7,196 |
Total income |
3,219,294 |
3,131,481 |
|
|
|
Total income comprises |
|
|
Dividends |
831,861 |
382,341 |
Interest |
2,385,330 |
2,741,944 |
Other income |
2,103 |
7,196 |
|
3,219,294 |
3,131,481 |
|
|
|
Total loan stock interest due but not recognised in the year was £905,181 (2017: £389,352). The increase over the year is due to the provision of interest of one investee company and another investee company utilising an agreed payment holiday for part of the year. |
|
4 |
Investment Adviser's fees and Other expenses |
|
All expenses are accounted for on an accruals basis |
|
|
a) |
Investment Adviser's fees and performance fees |
|
25% of the Investment Adviser's fee is charged to the revenue column of the Income Statement, while 75% is charged against the capital column of the Income Statement. This is in line with the Board's expected long-term split of returns from the investment portfolio of the Company. 100% of any performance incentive fee payable for the year is charged against the capital column of the Income Statement, as it is based upon the achievement of capital growth. |
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
2018 |
2018 |
2018 |
2017 |
2017 |
2017 |
|
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
Mobeus Equity Partners LLP |
|
|
|
|
|
|
Investment Adviser's fees |
390,531 |
1,171,593 |
1,562,124 |
350,079 |
1,050,237 |
1,400,316 |
|
Under the terms of a revised investment management agreement dated 20 May 2010, Mobeus Equity Partners LLP ("Mobeus") provides investment advisory, administrative and company secretarial services to the Company, for a fee of 2% per annum of closing net assets, paid in advance, calculated on a quarterly basis by reference to the net assets at the end of the preceding quarter, plus a fixed fee of £134,168 per annum, the latter inclusive of VAT and subject to annual increases in RPI. In 2013, Mobeus agreed to waive such further increases due to indexation, until otherwise agreed with the Board. The Investment Adviser's fee includes provision for a cap on expenses excluding irrecoverable VAT and exceptional items set at 3.6% of closing net assets at the year end. In accordance with the Investment Management Agreement, any excess expenses are borne by the Investment Adviser. The excess expenses during the year amounted to £nil (2017: £nil). With effect from 1 April 2018, the Investment Adviser's fee upon the net funds raised from use of the over-allotment facility of £10 million under the 2017/18 offer has been reduced from 2% to 1% per annum for one year. The Company is responsible for external costs such as legal and accounting fees, incurred on transactions that do not proceed to completion ("abort expenses") subject to the cap on total annual expenses referred to above. In line with common practice, Mobeus retains the right to charge arrangement and syndication fees and directors' or monitoring fees to companies in which the Company invests. The Investment Adviser received fees totalling £402,777 during the year ended 31 December 2018 (2017: £377,188), being £128,406 (2017: £118,381) for arrangement fees and £274,371 (2017: £258,807) for acting as non-executive directors on a number of investee company boards. These fees attributable to the Company are in proportion to the Company's investment directly in each investment held by the four Mobeus VCTs, and they are charged directly to the investee companies. Hence, they are excluded from these financial statements. |
|
Incentive Agreement |
|
Under the Incentive Agreement dated 9 July 2004, and a variation of this agreement dated 20 May 2010, the Investment Adviser is entitled to receive an annual performance-related incentive fee of 20% of the dividends paid in a year in excess of a "Target Rate" comprising firstly, an annual dividend paid in a year target which started at 6.00 pence per share on launch (indexed each year for RPI) and secondly a requirement that any shortfall of cumulative dividends paid in each year beneath the cumulative annual dividend target is carried forward and added to the Target Rate for the next accounting period. Any excess of cumulative dividends paid above the cumulative annual dividend target is not carried forward, whether an incentive fee is payable for that year or not. Payment of a fee is also conditional upon the daily weighted average Net Asset Value ("NAV") per share throughout such year equaling or exceeding the daily weighted average Base NAV per share throughout the same year. The performance fee will be payable annually. At 31 December 2018, the annual dividend target is 7.84 pence per share, but cumulative dividends paid of 5.00 pence were 2.84 pence less than the target. Also, the average NAV per share was 70.04 pence for the year, which was less than the average base NAV per share for the year of 91.76 pence. Accordingly, no performance incentive fee is payable for the year. |
|
b) |
Offer for subscription fees |
|
2018 |
2017 |
|
£m |
£m |
|
|
|
Funds raised across the four Mobeus VCTs |
19.64 |
60.36 |
of which the funds raised by MIG VCT were |
8.10 |
16.90 |
Offer costs payable to Mobeus at 3.25% of funds raised by MIG VCT |
0.26 |
0.55 |
|
Under the terms of an Offer for Subscription, with the other Mobeus advised VCTs, launched on 6 September 2017, Mobeus was entitled to fees of 3.25% of the investment amount received from investors. This amount totalled £638,236 for the final two allotments during the year across all four VCTs, out of which all the costs associated with the allotment were met, excluding any payments to advisers facilitated under the terms of the Offer. |
|
c) |
Other expenses |
|
Expenses are charged wholly to revenue, with the exception of expenses incidental to the acquisition or disposal of an investment, which are written off to the capital column of the Income Statement or deducted from the disposal proceeds as appropriate. |
|
|
2018 |
2017 |
|
£ |
£ |
|
|
|
Directors' remuneration (including NIC of £8,002 (2017: £8,110)) - note a) |
113,002 |
113,110 |
IFA trail commission |
81,025 |
87,580 |
Broker's fees |
14,400 |
14,400 |
Auditor's fees - Audit of Company (excluding VAT) |
24,088 |
23,832 |
- Audit related assurance services - note b) (excluding VAT) |
4,613 |
4,562 |
- tax compliance services - note b) (excluding VAT) |
1,922 |
1,358 |
Registrar's fees |
55,030 |
48,045 |
Printing |
28,084 |
27,299 |
Legal & professional fees |
10,422 |
7,918 |
VCT monitoring fees |
9,000 |
9,000 |
Directors' insurance |
7,630 |
8,153 |
Listing and regulatory fees |
29,526 |
30,114 |
Sundry |
8,490 |
10,046 |
Other expenses |
387,232 |
385,417 |
|
|
|
Note a): See analysis in the Directors' Remuneration Report in the Annual Report, which excludes the NIC above. The key management personnel are the three non-executive Directors. The Company has no employees. Note b): The audit related assurance services are in relation to the review of the Financial Statements within the Company's Half Year Report. The Audit Committee reviews the nature and extent of these services to ensure that auditor independence is maintained. In this regard, while iXBRL services are carried out by the auditor, the majority of compliance tax services are carried out by another firm, so are included within legal and professional fees. |
|
|
5 |
Taxation on profit/(loss) on ordinary activities |
|
|
The tax expense for the year comprises current tax and is recognised in profit or loss. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date. Any tax relief obtained in respect of adviser fees allocated to capital is reflected in the realised capital reserve and a corresponding amount is charged against revenue. The tax relief is the amount by which corporation tax payable is reduced as a result of these capital expenses. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the Company's taxable profits and its results as stated in the Financial Statements that arise from the inclusion of gains and losses in the tax assessments in periods different from those in which they are recognised in the Financial Statements. Deferred tax is measured at the average tax rates that are expected to apply in the years in which the timing differences are expected to reverse based on tax rates and laws that have been enacted or substantively enacted at the balance sheet date. Deferred tax is measured on a non-discounted basis. A deferred tax asset would be recognised only to the extent that it is more likely than not that future taxable profits will be available against which the asset can be utilised. |
|
Tax relief relating to Investment Adviser fees is allocated between revenue and capital where such relief can be utilised. The Company is an Investment Trust and Investment Trust companies are exempt from tax on capital gains if they meet the HMRC criteria set out in section 274 of the ITA. |
|
|
|
2018 |
2018 |
2018 |
2017 |
2017 |
2017 |
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
a) Analysis of tax charge: |
|
|
|
|
|
|
UK Corporation tax on profits/(losses) for the year |
331,416 |
(222,603) |
108,813 |
392,180 |
(202,170) |
190,010 |
Total current tax charge/(credit) |
331,416 |
(222,603) |
108,813 |
392,180 |
(202,170) |
190,010 |
Corporation tax is based on a rate of 19% (2017: 19.25%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
b) Profit on ordinary activities before tax |
2,441,531 |
1,495,699 |
3,937,230 |
2,395,985 |
3,625,960 |
6,021,945 |
|
|
|
|
|
|
|
Profit on ordinary activities multiplied by main company rate of corporation tax in the UK of 19% (2017: 19.25%) |
463,892 |
284,182 |
748,074 |
461,227 |
697,997 |
1,159,224 |
|
|
|
|
|
|
|
Effect of: |
|
|
|
|
|
|
UK dividends |
(132,816) |
- |
(132,816) |
(69,047) |
- |
(69,047) |
Unrealised (gains)/losses not taxable |
- |
(531,298) |
(531,298) |
- |
(110,237) |
(110,237) |
Realised losses/(gains) not taxable |
- |
24,513 |
24,513 |
- |
(1,010,404) |
(1,010,404) |
Unrelieved expenditure |
9 |
- |
9 |
- |
- |
- |
Underprovision in prior period |
331 |
- |
331 |
- |
- |
- |
Actual current tax charge |
331,416 |
(222,603) |
108,816 |
392,180 |
(202,170) |
190,010 |
|
|
|
|
|
|
|
Deferred taxation |
No provision for deferred taxation has been made on potential capital gains due to the Company's current status as a VCT under section 274 of the ITA and the Directors' intention to maintain that status. |
|
6 |
Dividends paid and payable |
|
|
|
|
|
|
|
Dividends payable are recognised as distributions in the Financial Statements when the Company's liability to pay them has been established. This liability is established for interim dividends when they are paid, and for final dividends when they are approved by the shareholders, usually at the Company's Annual General Meeting. A key judgement in applying the above accounting policy is in determining the amount of minimum dividend to be paid in respect of a year. The Company's status as a VCT means it has to comply with Section 259 of the ITA, which requires that no more than 15% of the income from shares and securities in a year can be retained from the revenue available for distribution for the year. |
|
|
|
|
|
|
|
Amounts recognised as distributions to equity shareholders in the year: |
|
|
|
|
|
|
|
|
|
Dividend |
Type |
For year ended 31 December |
Pence per share |
Date Paid |
2018 |
2017 |
£ |
£ |
|
|
|
|
|
|
|
Second Interim |
Capital |
2016 |
6.00p* |
31 Mar 2017 |
- |
4,535,848 |
Interim |
Capital |
2017 |
9.00p* |
13 Sep 2017 |
- |
6,796,071 |
Second Interim |
Capital |
2017 |
4.00p* |
8 Dec 2017 |
- |
3,900,003 |
Final |
Capital |
2017 |
1.50p |
17 May 2018 |
1,625,190 |
- |
Final |
Capital |
2017 |
0.50p |
17 May 2018 |
541,730 |
- |
Final |
Capital |
2017 |
1.00p* |
17 May 2018 |
1,083,459 |
- |
Interim |
Capital |
2018 |
2.00p* |
21 Sep 2018 |
2,159,518 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,409,897 |
15,231,922 |
|
|
|
|
|
|
|
Proposed distributions to equity holders at the year end: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Date Payable |
|
|
|
|
|
|
|
|
|
Final |
Income |
2017 |
1.50p |
17 May 2018 |
|
1,628,715 |
Final |
Capital |
2017 |
1.00p* |
17 May 2018 |
|
1,085,810 |
Final |
Capital |
2017 |
0.50p |
17 May 2018 |
|
542,905 |
Final |
Income |
2018 |
1.75p |
17 May 2019 |
1,870,153 |
- |
Final |
Capital |
2018 |
3.25p* |
17 May 2019 |
3,473,140 |
- |
|
|
|
|
|
5,343,293 |
3,257,430 |
|
*These dividends were and will be paid out of the Company's special distributable reserve. |
|
Set out below are the total income dividends payable in respect of the financial year, which is the basis on which the requirements of Section 259 of the ITA concerning the Company not retaining more than 15% of its income from shares and securities, is considered. |
|
Recognised income distributions in the financial statements for the year: |
|
Dividend |
Type |
For year ended 31 December |
Pence per share |
Date paid/payable |
2018 |
2017 |
£ |
£ |
|
|
|
Revenue available for distribution by way of dividends for the year |
2,110,115 |
2,003,805 |
|
|
|
|
|
|
|
|
|
|
Final |
Income |
2017 |
1.50p |
17 May 2018 |
- |
1,628,715 |
Final |
Income |
2018 |
1.75p |
17 May 2019 |
1,870,153 |
- |
|
|
|
|
|
|
|
Total income dividends for the year |
1,870,153 |
1,628,715 |
|
7 |
Basic and diluted earnings per share |
|
2018 |
2017 |
|
£ |
£ |
|
Total earnings after taxation: |
3,828,417 |
5,831,935 |
Basic and diluted earnings per share (note a) |
3.60p |
7.34p |
Revenue earnings from ordinary activities after taxation |
2,110,115 |
2,003,805 |
Basic and diluted revenue earnings per share (note b) |
1.98p |
2.52p |
|
|
|
Net unrealised capital gains/(losses) on investments |
2,796,306 |
-572,662 |
Net realised capital (losses)/gains on investments |
-129,014 |
5,248,859 |
Capital Investment Adviser fees less taxation |
-948,990 |
-848,067 |
Total capital earnings |
1,718,302 |
3,828,130 |
Basic and diluted capital earnings per share (note c) |
1.62p |
4.82p |
Weighted average number of shares in issue in the year |
106,350,801 |
79,475,780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes a) Basic earnings per share is total earnings after taxation divided by the weighted average number of shares in issue. b) Revenue earnings per share is the revenue earnings after taxation divided by the weighted average number of shares in issue. c) Capital earnings per share is the total capital earnings after taxation divided by the weighted average number of shares in issue. d) There are no instruments that will increase the number of shares in issue in future. Accordingly, the above figures currently represent both basic and diluted earnings per share. |
|
|
8 |
Investments at fair value |
|
The most critical estimates, assumptions and judgements relate to the determination of the carrying value of investments at "fair value through profit and loss" (FVTPL). All investments held by the Company are classified as FVTPL and measured in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") guidelines, as updated in December 2018. This classification is followed as the Company's business is to invest in financial assets with a view to profiting from their total return in the form of capital growth and income. Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional. For investments actively traded on organised financial markets, fair value is generally determined by reference to Stock Exchange market quoted bid prices at the close of business on the balance sheet date. Purchases and sales of quoted investments are recognised on the trade date where a contract of sale exists whose terms require delivery within a time frame determined by the relevant market where the terms of the disposal state that consideration may be received at some future date and, subject to the conditionality and materiality of the amount of deferred consideration, an estimate of the fair value, discounted for the true value of money, may be recognised through the Income Statement. In other cases, the proceeds will only be recognised once the right to receive payment is established and there is no reasonable doubt that payment will be received. Unquoted investments are stated at fair value by the Directors at each measurement date in accordance with appropriate valuation techniques, which are consistent with the IPEV guidelines: (i) Each investment is considered as a whole on a 'unit of account' basis, i.e. that the value of each portfolio company is considered as a whole, alongside consideration of: The price of new investments made, if deemed to be made as part of an orderly transaction, are considered to be at fair value at the date of the transaction. The inputs that derived the investment price are calibrated within individual valuation models and at subsequent measurement dates, are reconsidered for any changes in light of more recent events or changes in the market performance of the investee company such that the valuation bases used are the following: - a multiple basis. The shares may be valued by applying a suitable price-earnings ratio, revenue or gross profit multiple to that company's historic, current or forecast post-tax earnings before interest and amortisation, or revenue, or gross profit (the ratio used being based on a comparable sector but the resulting value being adjusted to reflect points of difference identified by the Investment Adviser compared to the sector including, inter alia, a lack of marketability). or: - where a company's underperformance against plan indicates a diminution in the value of the investment, provision against the price of a new investment is made, as appropriate. (ii) Premiums, to the extent that they are considered capital in nature, and that they will be received upon repayment of loan stock investments are accrued at fair value when the Company receives the right to the premium and when considered recoverable. (iii) Where a multiple or the price of recent investment less impairment basis is not appropriate and overriding factors apply, a discounted cash flow, net asset valuation or realisation proceeds basis may be applied. Capital gains and losses on investments, whether realised or unrealised, are dealt with in the profit and loss and revaluation reserves and movements in the period are shown in the Income Statement. All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement. A key judgement made in applying the above accounting policy relates to investments that are permanently impaired. Where the value of an investment has fallen permanently below the price of recent investment, the loss is treated as a permanent impairment and as a realised loss, even though the investment is still held. The Board assesses the portfolio for such investments and, after agreement with the Investment Adviser, will agree the values that represent the extent to which an investment loss has become realised. This is based upon an assessment of objective evidence of that investment's future prospects, to determine whether there is potential for the investment to recover in value. Accounting standards classify methods of fair value measurement as Levels 1, 2 and 3. This hierarchy is based upon the reliability of information used to determine the valuation. All of the unquoted investments are Level 3, i.e. fair value is measured using techniques using inputs that are not based on observable market data. |
|
Movements in investments during the year are summarised as follows: |
|
|
Unquoted ordinary shares |
Unquoted preference shares |
Unquoted Loan stock |
Total |
|
£ |
£ |
£ |
£ |
|
|
|
|
|
Cost at 31 December 2017 |
18,094,736 |
27,744 |
24,109,079 |
42,231,559 |
|
|
|
|
|
Net unrealised gains at 31 December 2017 |
243,148 |
718,633 |
1,825,001 |
2,786,782 |
|
|
|
|
|
Permanent impairment in value of investments as at 31 December 2017 |
(3,503,033) |
- |
- |
(3,503,033) |
|
|
|
|
|
|
|
|
|
|
Valuation at 31 December 2017 |
14,834,851 |
746,377 |
25,934,080 |
41,515,308 |
|
|
|
|
|
Purchases at cost |
4,509,556 |
- |
2,728,781 |
7,238,337 |
|
|
|
|
|
Sale proceeds (note a) (note b) |
(1,143,994) |
(185,711) |
(1,613,449) |
(2,943,154) |
|
|
|
|
|
Net realised gains/(losses) on investments (note a) |
827,043 |
- |
(956,057) |
(129,014) |
|
|
|
|
|
Net unrealised gains/(losses) on investments (note c) |
3,136,799 |
(1,459) |
(621,766) |
2,513,574 |
|
|
|
|
|
|
|
|
|
|
Valuation at 31 December 2018 |
22,164,255 |
559,207 |
25,471,589 |
48,195,051 |
|
|
|
|
|
Cost at 31 December 2018 |
21,631,195 |
27,663 |
25,080,727 |
46,739,585 |
|
|
|
|
|
Net unrealised gains at 31 December 2018 |
4,053,584 |
531,544 |
417,772 |
5,002,900 |
|
|
|
|
|
Permanent impairment in cost of investments as at 31 December 2018 (note f) |
(3,520,524) |
- |
(26,910) |
(3,547,434) |
|
|
|
|
|
|
|
|
|
|
Valuation at 31 December 2018 |
22,164,255 |
559,207 |
25,471,589 |
48,195,051 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note a) Disposals of investment portfolio companies during the year were: |
|
|
Type |
Investment cost |
Disposal proceeds |
Valuation at 31 December 2017 |
Realised gain in year |
|
|
£ |
£ |
£ |
£ |
|
|
|
|
|
|
Fullfield Limited (Motorclean) |
Full Exit |
1,625,672 |
917,491 |
1,703,367 |
(785,876) |
|
|
|
|
|
|
Lightworks Software Limited |
Full Exit |
222,584 |
941,737 |
160,446 |
781,291 |
|
|
|
|
|
|
Hemmels Limited1 |
Partial Exit and permanent impairment |
571,568 |
271,792 |
598,478 |
(326,686) |
|
|
|
|
|
|
The Plastic Surgeon Holdings Limited (formerly TPSFF Holdings Limited) |
Loan repayments and repurchase of preference shares |
153,589 |
465,957 |
465,957 |
- |
|
|
|
|
|
|
MPB Group |
Loan repayment |
143,920 |
143,920 |
143,920 |
- |
|
|
|
|
|
|
Other |
|
12,977 |
202,257 |
- |
202,257 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,730,310 |
2,943,154 |
3,072,168 |
(129,014) |
|
|
Net unrealised gains above of £2,513,574 differ from that shown in the Income Statement of £2,796,306. The difference of £282,732 is the estimated fair value of contingent consideration due in relation to the sale of Entanet Holdings in the prior year, recognised at the balance sheet date which has been included within other debtors in note 10 to the financial statements. The £282,732 contingent consideration also explains the difference between unrealised gains at 31 December 2018 above of £5,002,900 and that shown within the Revaluation Reserve on the balance sheet of £5,285,632. A further sum of £314,146 is potentially payable on 1 August 2019. There are conditions attached to this deferred consideration such that the amount receivable is uncertain and so has not been recognised in the current year's financial statements. |
|
1 New investment in year. |
|
Note b) Investment proceeds shown above of £2,943,154 differs from the sale proceeds shown in the Statement of Cash flows of £6,396,046 by £3,452,892. This difference arises because of proceeds relating to the disposal of Gro Group Holdings Limited that were held in debtors at the start of the year. Note c) The major components of the increase in unrealised valuations of £2,513,574 in the year were increases of £849,191 in The Plastic Surgeon Holdings Limited (formerly TPSFF Holdings Limited), £779,549 in EOTH Limited, £438,945 in CGI Creative Graphics International Limited, £423,681 in ASL Technology Holdings Limited, and £378,668 in Pattern Analytics Limited (trading as Biosite). This increase was partly offset by falls of £(833,001) in BookingTek Limited, £(802,114) in Manufacturing Services Investment Limited (trading as Wetsuit Outlet), £(679,012) in Veritek Global Holdings Limited, £(488,271) in Redline Worldwide Limited and £416,641 in Tharstern Group Limited. The decrease in unrealised valuations of the loan stock investments above reflects the changes in the entitlement to loan premiums, and/or in the underlying enterprise value of the investee company. The decrease does not arise from assessments of credit risk or market risk upon these instruments. Note d) During the year, permanent impairments of the cost of investments have increased from £3,503,033 to £3,547,434. The increase of £44,401 is due to the impairments of two investee companies, offset slightly by the disposal of a company that had previously been impaired. |
|
|
9 |
Current asset investments and Cash at bank |
|
Cash equivalents, for the purposes of the Statement of Cash flows, comprises bank deposits repayable on up to three months' notice and funds held in OEIC money-market funds. Current asset investments are the same but also include bank deposits that mature after three months. Current asset investments are disposable without curtailing or disrupting the business and are readily convertible into known amounts of cash at their carrying values at immediate or up to three months' notice. Cash, for the purposes of the Statement of Cash Flows is cash held with banks in accounts subject to immediate access. Cash at bank in the Balance Sheet is the same. |
|
|
2018 |
2017 |
£ |
£ |
|
|
|
OEIC Money market funds |
22,304,633 |
20,797,724 |
Cash equivalents per Statement of Cash Flows |
22,304,633 |
20,797,724 |
Bank deposits that mature after three months but are not immediately repayable |
1,005,682 |
1,005,552 |
Current asset investments |
23,310,315 |
21,803,276 |
Cash at bank |
3,181,475 |
3,027,719 |
|
10 |
Post balance sheet events |
|
On 31 January 2019, The Plastic Surgeon Holdings Limited (formerly TPSFF Holdings Limited) carried out a repurchase of preference shares in which £0.09 million of proceeds were received by the Company. On 7 February 2019, £0.31 million of contingent consideration was received in relation to the sale of Entanet Holdings in August 2017. |
|
11 |
Statutory information |
|
The financial information set out in these statements does not constitute the Company's statutory accounts for the year ended 31 December 2018 but is derived from those accounts. Statutory accounts will be delivered to the Registrar of Companies after the Annual General Meeting. The auditors have reported on these accounts and their report was unqualified and did not contain a statement under section 498(2) of the Companies Act 2006. |
|
12 |
Annual Report |
|
|
The Annual Report will be published on the Company's website at www.migvct.co.uk shortly and shareholders who have not requested a hard copy of the report will shortly receive notification from the Company on how to download a pdf of the Report from the website. Shareholders and members of the public who wish to receive a hard copy of the Annual Report, may request a copy by writing to the Company Secretary, Mobeus Equity Partners LLP, 30 Haymarket (4th floor), London SW1Y 4EX or by email: [email protected]. |
|
13 |
Annual General Meeting |
|
The Annual General Meeting of the Company will be held at 2.00 p.m. on Wednesday, 8 May 2019 at The Clubhouse, 8 St James's Square, London, SW1Y 4JU. Contact details for further enquiries: Robert King or Robert Brittain of Mobeus Equity Partners LLP (the Company Secretary) on 020 7024 7600 or by e-mail to [email protected]. Mark Wignall at Mobeus Equity Partners LLP (the Investment Adviser) on 020 7024 7600 or by e-mail to [email protected]. |
|
DISCLAIMER |
|
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|